Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H29NO2 |
Molecular Weight | 327.4605 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)CCCN1C=C(C(=O)C2C(C)(C)C2(C)C)C3=CC=CC=C13
InChI
InChIKey=YHFHYHZNLCEAAP-UHFFFAOYSA-N
InChI=1S/C21H29NO2/c1-14(23)9-8-12-22-13-16(15-10-6-7-11-17(15)22)18(24)19-20(2,3)21(19,4)5/h6-7,10-11,13-14,19,23H,8-9,12H2,1-5H3
Molecular Formula | C21H29NO2 |
Molecular Weight | 327.4605 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26514671Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24812645 | https://www.ncbi.nlm.nih.gov/pubmed/26792810 | https://www.ncbi.nlm.nih.gov/pubmed/26514671
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26514671
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24812645 | https://www.ncbi.nlm.nih.gov/pubmed/26792810 | https://www.ncbi.nlm.nih.gov/pubmed/26514671
UR-144 N(4-hydroxypentyl) is a potent synthetic cannabinoid designed by Abbott Laboratories as a CB2 selective agonist for pain management. UR-144 N(4-hydroxypentyl) is a metabolite of another CB2-selective cannabinoid UR-144. Pre-clinical studies of nociceptive and neuropathic pain have shown that CB2-selective ligands are analgesics without causing the adverse side effects linked with CB1 receptor activation. However, nor UR-144 nor UR-144 N(4-hydroxypentyl) has no therapeutic application.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28771321 |
|||
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28771321 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28771321
Phoenix Amphotropic (AMPHO) cell line were washed twice with Opti-MEM I Reduced Serum Medium to remove any remaining FBS, and 100 μL of Opti-MEM I was added. The Nano-Glo Live Cell reagent (Promega), a nonlytic detection reagent containing the cell permeable furimazine substrate, was prepared by diluting the Nano-Glo Live Cell substrate 20× using Nano-Glo LCS Dilution buffer, and 25 μL was added to each well. Subsequently, the plate was placed in a luminometer, the GloMAX96 (Promega). Luminescence was monitored during the equilibration period until the signal stabilized (30−45 min). For agonist experiments, we added 10 μL per well of test compounds (UR-144 N-pentanoic acid), present as 13.5× stocks in 50% methanol in Opti-MEM I. The luminescence was continuously detected for 120 min. Solvent controls were run in all experiments; the final concentration of methanol (3.7%) did not pose a problem given the short readout time of the assay.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:20:11 GMT 2023
by
admin
on
Sat Dec 16 11:20:11 GMT 2023
|
Record UNII |
HOM2IB42C4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID801043116
Created by
admin on Sat Dec 16 11:20:11 GMT 2023 , Edited by admin on Sat Dec 16 11:20:11 GMT 2023
|
PRIMARY | |||
|
91736656
Created by
admin on Sat Dec 16 11:20:11 GMT 2023 , Edited by admin on Sat Dec 16 11:20:11 GMT 2023
|
PRIMARY | |||
|
HOM2IB42C4
Created by
admin on Sat Dec 16 11:20:11 GMT 2023 , Edited by admin on Sat Dec 16 11:20:11 GMT 2023
|
PRIMARY | |||
|
1537889-04-5
Created by
admin on Sat Dec 16 11:20:11 GMT 2023 , Edited by admin on Sat Dec 16 11:20:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
22 ng/mL (serum, ER arrival); 10 ng/mL (serum, 10h after ER arrival)
IN-VIVO
Scientific Literature
|